Author = Septelia Inawati Wanandi
Conjugation of Cetuximab – Puromycin and Its Target-Specific Effect on Triple Negative Breast Cancer Cell Lines

Volume 23, Issue 5, May 2022, Pages 1803-1812

Diah Puspitasari; Septelia I Wanandi; Mohamad Sadikin


Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role

Volume 20, Issue 12, December 2019, Pages 3689-3695

Ikhwan Rinaldi; Ary Harryanto Reksodiputro; Sri Widia Jusman; Alida Harahap; Rianto Setiabudy; Septelia Inawati Wanandi; Karmel Tambunan; Catharina Suharti


Curcumin for the Prevention of Epithelial-Mesenchymal Transition in Endoxifen-Treated MCF-7 Breast Cancer Cells

Volume 19, Issue 5, May 2018, Pages 1243-1249

P Paramita; Bantari WK Wardhani; Septelia Inawati Wanandi; Melva Louisa